EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GERI Study: Gathering Evidence and Real-World Insights in Osteoarthritis Management With Native (Undenatured) Type II Collagen

Vivek Kumar, Udaybhan Mourya, Rajiv Gupta, Nirmalya Deb, Madhusudan Biyani, Dayashankar Rao Madan Temker, A. Anjan, Onkar Swami, Kamal Kumar

Journal of Orthopaedic Association of South Indian States · 2026-01 · 23 (1) · 9-18

DOI: 10.4103/joasis.joasis_7_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Association of South Indian States, online erschienen am 11.07.2026. Verfasst von Vivek Kumar und 8 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis (OA) is a progressive joint disorder and is increasingly prevalent in India. Conventional therapies offer symptomatic relief but do not address the underlying disease process. native (undenatured) type II collagen, a symptomatic slow-acting drug, has emerged as a promising adjunct in OA management due to its ability to modulate immune response and improve joint function.

Objective

The gathering evidence and real-world insights (GERI) study aimed to assess the knowledge, attitudes, and practices (KAP) of Indian orthopedic healthcare providers (HCPs) regarding the clinical use of native (undenatured) type II collagen in OA management. Materials and Methods: A cross-sectional, questionnaire-based study was conducted among 416 orthopedic HCPs across India. It evaluated OA prevalence, treatment strategies, native (undenatured) type II collagen efficacy and safety, and quality-of-life outcomes using structured KAP questionnaires.

Results

The majority of HCPs (95.1%) favored collagen supplementation, with 61% preferring native (undenatured) type II collagen. Over 74% recommended native (undenatured) type II collagen alongside pharmacologic therapy. Native (undenatured) type II collagen was most often initiated in early OA, with 60.2% reporting symptom improvement within 1–3 months. It was rated superior to glucosamine and chondroitin in adherence, efficacy, and tolerability. Additionally, 74.5% observed a reduction in nonsteroidal anti-inflammatory drugs use. Physical therapy and weight management were the most commonly recommended adjuncts.

Conclusion

The GERI study highlights strong clinical acceptance of native (undenatured) type II collagen among Indian orthopedic HCPs as an effective and well-tolerated adjunct in OA management. Its early use, combined with lifestyle interventions, may offer sustainable benefits in improving patient outcomes and reducing reliance on conventional drugs. Clinical Trial Registration: ICEDH/20s24/11.

Zitieren

APA

Kumar, V., Mourya, U., Gupta, R., Deb, N., Biyani, M., Temker, D. R. M., Anjan, A., Swami, O., & Kumar, K. (2026). GERI Study: Gathering Evidence and Real-World Insights in Osteoarthritis Management With Native (Undenatured) Type II Collagen. Journal of Orthopaedic Association of South Indian States, 23(1), 9-18. https://doi.org/10.4103/joasis.joasis_7_26

Vancouver

Kumar V, Mourya U, Gupta R, Deb N, Biyani M, Temker DRM, et al. GERI Study: Gathering Evidence and Real-World Insights in Osteoarthritis Management With Native (Undenatured) Type II Collagen. Journal of Orthopaedic Association of South Indian States. 2026;23(1):9-18. doi:10.4103/joasis.joasis_7_26

BibTeX
@article{Kumar2026,
  author = {Kumar, Vivek and Mourya, Udaybhan and Gupta, Rajiv and Deb, Nirmalya and Biyani, Madhusudan and Temker, Dayashankar Rao Madan and Anjan, A. and Swami, Onkar and Kumar, Kamal},
  title = {GERI Study: Gathering Evidence and Real-World Insights in Osteoarthritis Management With Native (Undenatured) Type II Collagen},
  journal = {Journal of Orthopaedic Association of South Indian States},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {9--18},
  doi = {10.4103/joasis.joasis_7_26}
}
Kostenlos starten →